Fit-For-Purpose PD-L1 Biomarker Testing for Patient Selection in Immuno-Oncology: Guidelines for Clinical Laboratories from the Canadian Association of Pathologists-Association Canadienne des Pathologistes (CAP-ACP)

Canadian Association of Pathologists-Association Canadienne Des Pathologistes' National Standards Committee for High Complexity Testing (CAP-ACP NSCHCT)

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Fit-For-Purpose PD-L1 Biomarker Testing for Patient Selection in Immuno-Oncology: Guidelines for Clinical Laboratories from the Canadian Association of Pathologists-Association Canadienne des Pathologistes (CAP-ACP)'. Together they form a unique fingerprint.

Medicine & Life Sciences